Genetic susceptibility to invasive Salmonella disease

Nature Reviews Immunology

Volumn 15, Issue 7, 2015, Pages 452-463

  Gilchrist, James J ^a   MaClennan, Calman A ^b,c   Hill, Adrian V S ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DIVALENT CATION; GAMMA INTERFERON; INFLAMMASOME; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR;

AUTOPHAGY; B LYMPHOCYTE; CYTOKINE PRODUCTION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HOST SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOBIOLOGY; INNATE IMMUNITY; INVASIVE NONTYPHOIDAL SALMONELLA DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TYPHOID FEVER; ANIMAL; GENETIC PREDISPOSITION; GENETICS;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; SALMONELLA INFECTIONS;

EID: 84933043357     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3858     Document Type: Review

References (117)

1. Wain, J., Hendriksen, R. S., Mikoleit, M. L., Keddy, K. H. & Ochiai, R. L. Typhoid fever. Lancet 385, 1136-1145 (2015).
2. MacLennan, C. A. & Levine, M. M. Invasive nontyphoidal Salmonella disease in Africa: current status. Expert Rev. Anti Infect. Ther. 11, 443-446 (2013).
3. Crump, J. A., Luby, S. P. & Mintz, E. D. The global burden of typhoid fever. Bull. World Health Organ. 82, 346-353 (2004).
4. Reddy, E. A., Shaw, A. V. & Crump, J. A. Community-Acquired bloodstream infections in Africa: a systematic review and meta-Analysis. Lancet Infect. Dis. 10, 417-432 (2010).
5. Sørensen, T. I., Nielsen, G. G., Andersen, P. K. & Teasdale, T. W. Genetic and environmental influences on premature death in adult adoptees. N. Engl. J. Med. 318, 727-732 (1988).
6. Dunstan, S. J. et al. Variation at HLA-DRB1 is associated with resistance to enteric fever. Nat. Genet. 46, 1333-1336 (2014).
7. Malaria Genomic Epidemiology Network. Reappraisal of known malaria resistance loci in a large multicenter study. Nat. Genet. 46, 1197-1204 (2014).
8. Khor, C. C. et al. CISH and susceptibility to infectious diseases. N. Engl. J. Med. 362, 2092-2101 (2010).
9. Khor, C. C. et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat. Genet. 39, 523-528 (2007).
10. Santos, R. L. et al. Animal models of Salmonella infections: enteritis versus typhoid fever. Microbes Infect. 3, 1335-1344 (2001).
11. Hormaeche, C. E. Natural resistance to Salmonella typhimurium in different inbred mouse strains. Immunology 37, 311-318 (1979).
12. Hormaeche, C. E., Mastroeni, P., Arena, A., Uddin, J. & Joysey, H. S. T cells do not mediate the initial suppression of a Salmonella infection in the RES. Immunology 70, 247-250 (1990).
13. Hess, J., Ladel, C., Miko, D. & Kaufmann, S. H. Salmonella typhimurium aroA-infection in gene-Targeted immunodeficient mice: major role of CD4+ TCR-αβ cells and IFN? in bacterial clearance independent of intracellular location. J. Immunol. 156, 3321-3326 (1996).
14. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088 (1998).
15. Broz, P. et al. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 490, 288-291 (2013).
16. Muotiala, A. & Mokelo, P. H. The role of IFN-? in murine Salmonella typhimurium infection. Microb. Pathog. 8, 135-141 (1990).
17. Mastroeni, P. et al. Serum TNFα in mouse typhoid and enhancement of a Salmonella infection by anti-TNFα antibodies. Microb. Pathog. 11, 33-38 (1991).
18. Mastroeni, P. et al. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J. Exp. Med. 192, 237-248 (2000).
19. Vidal, S. et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J. Exp. Med. 182, 655-666 (1995).
20. Kawai, T. & Akira, S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637-650 (2011).
21. Robson, H. G. & Vas, S. I. Resistance of inbred mice to Salmonella typhimurium. J. Infect. Dis. 126, 378-386 (1972).
22. Weiss, D. S., Raupach, B., Takeda, K., Akira, S. & Zychlinsky, A. Toll-like receptors are temporally involved in host defense. J. Immunol. 172, 4463-4469 (2004).
23. Feuillet, V. et al. Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria. Proc. Natl Acad. Sci. USA 103, 12487-12492 (2006).
24. Arpaia, N. et al. TLR signaling is required for Salmonella typhimurium virulence. Cell 144, 675-688 (2011).
25. Sivick, K. E. et al. Toll-like receptor-deficient mice reveal how innate immune signaling influences Salmonella virulence strategies. Cell Host Microbe 15, 203-213 (2014).
26. Hanson, E. P. et al. Hypomorphic nuclear factor-?B essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J. Allergy Clin. Immunol. 122, 1169-1193 (2008).
27. Janssen, R. et al. The same I?Bα mutation in two related individuals leads to completely different clinical syndromes. J. Exp. Med. 200, 559-568 (2004).
28. Filipe-Santos, O. et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J. Exp. Med. 203, 1745-1759 (2006).
29. Picard, C., Casanova, J. L. & Puel, A. Infectious diseases in patients with IRAK-4, MyD88, NEMO, or I?Bα deficiency. Clin. Microbiol. Rev. 24, 490-497 (2011).
30. Ferwerda, B. et al. Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock. Proc. Natl Acad. Sci. USA 106, 10272-10277 (2009).
31. Bhuvanendran, S. et al. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and typhoid susceptibility in Asian Malay population in Malaysia. Microbes Infect. 13, 844-851 (2011).
32. Hue, N. T. et al. Toll-like receptor 4 (TLR4) and typhoid fever in vietnam. PLoS ONE 4, e4800 (2009).
33. Dunstan, S. J. et al. Host susceptibility and clinical outcomes in toll-like receptor 5-deficient patients with typhoid fever in Vietnam. J. Infect. Dis. 191, 1068-1071 (2005).
34. Broz, P. et al. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J. Exp. Med. 207, 1745-1755 (2010).
35. Kayagaki, N. et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341, 1246-1249 (2013).
36. Franchi, L., Warner, N., Viani, K. & Nunez, G. Function of Nod-like receptors in microbial recognition and host defense. Immunol. Rev. 227, 106-128 (2009).
37. Raupach, B., Peuschel, S. K., Monack, D. M. & Zychlinsky, A. Caspase-1-mediated activation of interleukin-1β (IL-1β) and IL-18 contributes to innate immune defenses against Salmonella enterica serovar Typhimurium infection. Infect. Immun. 74, 4922-4926 (2006).
38. Ali, S. et al. Polymorphisms in proinflammatory genes and susceptibility to typhoid fever and paratyphoid fever. J. Interferon Cytokine Res. 27, 271-280 (2007).
39. Conlan, J. W. Neutrophils prevent extracellular colonization of the liver microvasculature by Salmonella typhimurium. Infect. Immun. 64, 1043-1047 (1996).
40. Cunnington, A. J., de Souza, J. B., Walther, M. & Riley, E. M. Malaria impairs resistance to Salmonella through heme-And heme oxygenase-dependent dysfunctional granulocyte mobilization. Nat. Med. 18, 120-127 (2012).
41. Cunnington, A. J. et al. Prolonged neutrophil dysfunction after Plasmodium falciparum malaria is related to hemolysis and heme oxygenase-1 induction. J. Immunol. 189, 5336-5346 (2012).
42. Kawai, T., Adachi, O., Ogawa, T., Takeda, K. & Akira, S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115-122 (1999).
43. Mastroeni, P., Harrison, J. A., Chabalgoity, J. A. & Hormaeche, C. E. Effect of interleukin 12 neutralization on host resistance and ? interferon production in mouse typhoid. Infect. Immun. 64, 189-196 (1996).
44. Mastroeni, P. et al. Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation. Infect. Immun. 66, 4767-4776 (1998).
45. Kupz, A. et al. Contribution of Thy1+ NK cells to protective IFN-? production during Salmonella typhimurium infections. Proc. Natl Acad. Sci. USA 110, 2252-2257 (2013).
46. Newport, M. J. et al. A mutation in the interferon-?-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335, 1941-1949 (1996).
47. Dorman, S. E. et al. Clinical features of dominant and recessive interferon ? receptor 1 deficiencies. Lancet 364, 2113-2121 (2004).
48. Prando, C. et al. Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds. Medicine (Baltimore) 92, 109-122 (2013).
49. de Beaucoudrey, L. et al. Revisiting human IL-12Rβ1 deficiency. Medicine (Baltimore) 89, 381-402 (2010).
50. Averbuch, D., Chapgier, A., Boisson-Dupuis, S., Casanova, J.-L. & Engelhard, D. The clinical spectrum of patients with deficiency of signal transducer and activator of transcription-1. Pediatr. Infect. Dis. J. 30, 352-355 (2011).
51. Minegishi, Y. et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25, 745-755 (2006).
52. Browne, S. K. et al. Adult-onset immunodeficiency in Thailand and Taiwan. N. Engl. J. Med. 367, 725-734 (2012).
53. Jong, R. D. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280, 1435-1438 (1998).
54. Jouanguy, E. et al. In a novel form of IFN-? receptor 1 deficiency, cell surface receptors fail to bind IFN-?. J. Clin. Invest. 105, 1429-1436 (2000).
55. Ohmori, Y., Schreiber, R. D. & Hamilton, T. A. Synergy between interferon-? and tumor necrosis factor-α in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor ?B. J. Biol. Chem. 272, 14899-14907 (1997).
56. Everest, P., Roberts, M. & Dougan, G. Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor α p55 receptor. Infect. Immun. 66, 3355-3364 (1998).
57. Pe?a-Sagredo, J. L. et al. Non-Typhi Salmonella infection in patients with rheumatic diseases on TNF-α antagonist therapy. Clin. Exp. Rheumatol. 27, 920-925 (2009).
58. Bassetti, M., Nicco, E., Delfino, E. & Viscoli, C. Disseminated Salmonella paratyphi infection in a rheumatoid arthritis patient treated with infliximab. Clin. Microbiol. Infect. 16, 84-85 (2010).
59. Dunstan, S. J. et al. A TNF region haplotype offers protection from typhoid fever in Vietnamese patients. Hum. Genet. 122, 51-61 (2007).
60. MacMicking, J. D. Interferon-inducible effector mechanisms in cell-Autonomous immunity. Nat. Rev. Immunol. 12, 367-382 (2012).
61. Kagaya, K., Watanabe, K. & Fukazawa, Y. Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity. Infect. Immun. 57, 609-615 (1989).
62. Khan, R. T., Yuki, K. E. & Malo, D. Fine-mapping and phenotypic analysis of the Ity3 Salmonella susceptibility locus identify a complex genetic structure. PLoS ONE 9, e88009 (2014).
63. Segal, B. H., Leto, T. L., Gallin, J. I., Malech, H. L. & Holland, S. M. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 79, 170-200 (2000).
64. Winkelstein, J. A. et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79, 155-169 (2000).
65. Williams, T. N. et al. Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study. Lancet 374, 1364-1370 (2009).
66. Mabey, D. C., Brown, A. & Greenwood, B. M. Plasmodium falciparum malaria and Salmonella infections in Gambian children. J. Infect. Dis. 155, 1319-1321 (1987).
67. Wanachiwanawin, W. Infections in E-β thalassemia. J. Pediatr. Hematol. Oncol. 22, 581-587 (2000).
68. Roy, M.-F. et al. Pyruvate kinase deficiency confers susceptibility to Salmonella typhimurium infection in mice. J. Exp. Med. 204, 2949-2961 (2007).
69. Ampel, N. M., Van Wyck, D. B., Aguirre, M. L., Willis, D. G. & Popp, R. A. Resistance to infection in murine β-Thalassemia. Infect. Immun. 57, 1011-1017 (1989).
70. Yuki, K. E. et al. Suppression of hepcidin expression and iron overload mediate Salmonella susceptibility in ankyrin 1 ENU-induced mutant. PLoS ONE 8, e55331 (2013).
71. Hooke, W., Kaye, D. & Gill, F. A. Factors influencing host resistance to Salmonella infection. The effects of hemolysis and erythrophagocytosis. Trans. Am. Clin. Climatol. Assoc. 78, 230-241 (1967).
72. Govoni, G., Gauthier, S., Billia, F., Iscove, N. N. & Gros, P. Cell-specific and inducible Nramp1 gene expression in mouse macrophages in vitro and in vivo. J. Leukoc. Biol. 62, 277-286 (1997).
73. Jabado, N. et al. Natural resistance to intracellular infections: natural resistance-Associated macrophage protein 1 (Nramp1) functions as a pH-dependent manganese transporter at the phagosomal membrane. J. Exp. Med. 192, 1237-1248 (2000).
74. Fritsche, G., Nairz, M., Libby, S. J., Fang, F. C. & Weiss, G. Slc11a1 (Nramp1) impairs growth of Salmonella enterica serovar Typhimurium in macrophages via stimulation of lipocalin-2 expression. J. Leukoc. Biol. 92, 353-359 (2012).
75. Nairz, M. et al. Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood 114, 3642-3651 (2009).
76. Cairo, G. et al. Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. Blood 89, 2546-2553 (1997).
77. Dunstan, S. J. et al. Typhoid fever and genetic polymorphisms at the natural resistance-Associated macrophage protein 1. J. Infect. Dis. 183, 1156-1160 (2001).
78. Birmingham, C. L., Smith, A. C., Bakowski, M. A., Yoshimori, T. & Brumell, J. H. Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J. Biol. Chem. 281, 11374-11383 (2006).
79. Conway, K. L. et al. Atg16l1 is required for autophagy in intestinal epithelial cells and protection of mice from Salmonella infection. Gastroenterology 145, 1347-1357 (2013).
80. Ali, S. et al. PARK2/PACRG polymorphisms and susceptibility to typhoid and paratyphoid fever. Clin. Exp. Immunol. 144, 425-431 (2006).
81. Liang-Takasaki, C. J., Sax?n, H., Mokelo, P. H. & Leive, L. Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae. Infect. Immun. 41, 563-569 (1983).
82. Warren, J. et al. Increased susceptibility of C1q-deficient mice to Salmonella enterica serovar Typhimurium infection. Infect. Immun. 70, 551-557 (2002).
83. Johnston, R. B., Newman, S. L. & Struth, A. G. An abnormality of the alternate pathway of complement activation in sickle-cell disease. N. Engl. J. Med. 288, 803-808 (1973).
84. Ross, S. C. & Densen, P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 63, 243-273 (1984).
85. MacLennan, C. A. et al. The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J. Clin. Invest. 118, 1553-1562 (2008).
86. Sinha, K., Mastroeni, P., Harrison, J., de Hormaeche, R. D. & Hormaeche, C. E. Salmonella typhimurium aroA, htrA, and aroD htrA mutants cause progressive infections in athymic (nu/nu) BALB/c mice. Infect. Immun. 65, 1566-1569 (1997).
87. Lee, S.-J., Dunmire, S. & McSorley, S. J. MHC class-I-restricted CD8 T cells play a protective role during primary Salmonella infection. Immunol. Lett. 148, 138-143 (2012).
88. Mastroeni, P., Villarreal-Ramos, B. & Hormaeche, C. E. Role of T cells, TNFα and IFN? in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro-Salmonella vaccines. Microb. Pathog. 13, 477-491 (1992).
89. Mastroeni, P., Simmons, C., Fowler, R., Hormaeche, C. E. & Dougan, G. Igh-6-/-(B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar Typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infect. Immun. 68, 46-53 (2000).
90. MacLennan, C. et al. Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J. Infect. Dis. 190, 1755-1757 (2004).
91. de Beaucoudrey, L. et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J. Exp. Med. 205, 1543-1550 (2008).
92. Raffatellu, M. et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat. Med. 14, 421-428 (2008).
93. Peck, A. & Mellins, E. D. Precarious balance: Th17 cells in host defense. Infect. Immun. 78, 32-38 (2010).
94. Ahmad, D. S., Esmadi, M. & Steinmann, W. C. Idiopathic CD4 lymphocytopenia: spectrum of opportunistic infections, malignancies, and autoimmune diseases. Avicenna J. Med. 3, 37-47 (2013).
95. Hormaeche, C. E., Harrington, K. A. & Joysey, H. S. Natural resistance to salmonellae in mice: control by genes within the major histocompatibility complex. J. Infect. Dis. 152, 1050-1056 (1985).
96. Klein, C., Lisowska-Grospierre, B., LeDeist, F., Fischer, A. & Griscelli, C. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J. Pediatr. 123, 921-928 (1993).
97. Dharmana, E. et al. HLA-DRB1.12 is associated with protection against complicated typhoid fever, independent of tumour necrosis factor α. Eur. J. Immunogenet. 29, 297-300 (2002).
98. Dunstan, S. J. et al. Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam. J. Infect. Dis. 183, 261-268 (2001).
99. Cummings, L. A., Barrett, S. L. R., Wilkerson, W. D., Fellnerova, I. & Cookson, B. T. FliC-specific CD4+ T cell responses are restricted by bacterial regulation of antigen expression. J. Immunol. 174, 7929-7938 (2005).
100. Lee, S.-J. et al. Temporal expression of bacterial proteins instructs host CD4 T cell expansion and Th17 development. PLoS Pathog. 8, e1002499 (2012).
101. Mastroeni, P., Villarreal-Ramos, B. & Hormaeche, C. E. Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells. Infect. Immun. 61, 3981-3984 (1993).
102. Nanton, M. R., Way, S. S., Shlomchik, M. J. & McSorley, S. J. Cutting edge: B cells are essential for protective immunity against Salmonella independent of antibody secretion. J. Immunol. 189, 5503-5507 (2012).
103. Hermaszewski, R. A. & Webster, A. D. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q. J. Med. 86, 31-42 (1993).
104. Winkelstein, J. A. et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 85, 193-202 (2006).
105. Levy, J., Espanol-Boren, T., Thomas, C. & Fischer, A. Clinical spectrum of X-linked hyper-IgM syndrome. J. Pediatr. 131, 47-54 (1997).
106. Fraser, A., Paul, M., Goldberg, E., Acosta, C. J. & Leibovici, L. Typhoid fever vaccines: systematic review and meta-Analysis of randomised controlled trials. Vaccine 25, 7848-7857 (2007).
107. Feasey, N. A., Dougan, G., Kingsley, R. A., Heyderman, R. S. & Gordon, M. A. Invasive non-Typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 379, 2489-2499 (2012).
108. Geldmacher, C. et al. Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection. J. Infect. Dis. 198, 1590-1598 (2008).
109. Dandekar, S., George, M. D. & Bäumler, A. J. Th17 cells, HIV and the gut mucosal barrier. Curr. Opin. HIV AIDS 5, 173-178 (2010).
110. MacLennan, C. A. et al. Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults. Science 328, 508-512 (2010).
111. Mastroeni, P., Grant, A., Restif, O. & Maskell, D. A dynamic view of the spread and intracellular distribution of Salmonella enterica. Nat. Rev. Microbiol. 7, 73-80 (2009).
112. Crump, J. A., Ram, P. K., Gupta, S. K., Miller, M. A. & Mintz, E. D. Part I. Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries, 1984-2005. Epidemiol. Infect. 136, 436-448 (2008).
113. Gordon, M. A. et al. Epidemics of invasive Salmonella enterica serovar Enteritidis and S. enterica serovar Typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin. Infect. Dis. 46, 963-969 (2008).
114. Crump, J. A. & Mintz, E. D. Global trends in typhoid and paratyphoid fever. Clin. Infect. Dis. 50, 241-246 (2010).
115. MacLennan, C. A., Martin, L. B. & Micoli, F. Vaccines against invasive Salmonella disease: current status and future directions. Hum. Vaccin. Immunother. 10, 1478-1493 (2014).
116. Pier, G. B. et al. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 393, 79-82 (1998).
117. van de Vosse, E. et al. Distribution of CFTR variations in an Indonesian enteric fever cohort. Clin. Infect. Dis. 50, 1231-1237 (2010).